Rising Demand for Prenatal Screening and advanced molecular diagnostics Fuel a Steady 7.28% CAGR Growth
Austin, United States, April 21, 2026 (GLOBE NEWSWIRE) — According to SNS Insider, The Zika Virus Testing Market size is valued at USD 239.91 Million in 2025 and is projected to reach USD 480.44 Million by 2035, growing at a CAGR of 7.28% during 2026–2035. The surge reflects increasing global vigilance toward vector-borne diseases, alongside technological advancements in diagnostic solutions.
Market Size and Forecast:
- Market Size (2025): USD 239.91 Million
- Market Size (2035): USD 480.44 Million
- CAGR (2026–2035): 7.28%
- Base Year: 2025
- Forecast Period: 2026–2035
- Historical Data: 2022–2024
Get a Sample Report of Zika Virus Testing Market: https://www.snsinsider.com/sample-request/9896
Rising Outbreak Preparedness is Augmenting the Market Expansion Globally
Advanced molecular diagnostics, multiplex technologies, and quick point-of-care kits are being used more frequently by healthcare organizations such as hospitals and diagnostic labs to detect the Zika virus, avoid congenital issues, and manage the outbreak. Developments in quick kits, automated surveillance reporting, and portable PCR technologies are driving the usage of these tools to identify the Zika virus, improving test accuracy, and driving market expansion.
Major Zika Virus Testing Market Companies Listed in the Report are
- Roche
- Abbott Laboratories
- Thermo Fisher Scientific
- Quest Diagnostics
- ARUP Laboratories
- Eurofins Scientific
- DiaSorin
- Chembio Diagnostics
- Hologic
- Luminex Corporation
- Siemens Healthineers
- Altona Diagnostics
- Creative Diagnostics
- InBios International
- Biocan Diagnostics
- QIAGEN
- bioMérieux
- Bio-Rad Laboratories
- Access Bio
- Becton Dickinson (BD)
Segmentation Analysis:
By Test Type
Serological / Antibody Tests held the largest market share of 61.46% in 2025 due to the high volume of tests conducted in large-scale screening programs, cost-effectiveness, and existing clinical acceptance in hospitals, labs, and health organizations. Molecular / NAAT (PCR, RT-PCR) are expected to grow at the fastest CAGR of 7.41% during 2026–2035 due to the growing need for accurate diagnostic tests, prenatal and neonatal screening.
By Technology
Nucleic Acid Amplification (PCR, RT-PCR, qPCR) dominated with 46.55% market share in 2025 and is also projected to record the fastest CAGR of 6.79% through 2026–2035 owing to its accuracy, reliability, and acceptance by hospitals, diagnostic centers, and public health authorities.
By Application
Clinical Diagnosis accounted for the highest market share of 49.12% in 2025 due to the use of tests in hospitals, clinics, and diagnostic labs for symptomatic patients as well as prenatal screening. Public Health Surveillance & Outbreak Control are expected to grow at the fastest CAGR of 6.71% during the forecast period due to increasing government initiatives, WHO/PAHO-endorsed programs, and the need to quickly respond to epidemics.
By End User
Hospitals & Clinics held the largest share of 47.72% in 2025 due to their importance in the management of patients presenting with symptoms, prenatal screening, and outbreak response. Diagnostic Units / Pathology Labs are expected to grow at the fastest CAGR of 6.82% during the forecast period due to the increasing need for specialized molecular tests, the use of multiplex tests, and the increasing capacity to support large-scale screening during epidemics.
Do you have any specific queries or need any customization research on Zika Virus Testing Market, make an Enquiry Now: https://www.snsinsider.com/enquiry/9896
Zika Virus Testing Market Key Segments
By Test Type
- Serological / Antibody Tests
- Molecular / NAAT (PCR, RT-PCR)
- Rapid Diagnostic Kits (EUA-based)
- Others
By Technology
- Nucleic Acid Amplification (PCR, RT-PCR, qPCR)
- ELISA / Serological Assays
- Point-of-Care Rapid Kits
- Others
By Application
- Clinical Diagnosis
- Public Health Surveillance & Outbreak Control
- Travel & Preventive Screening
- Research & Academic Studies
- Others
By End User
- Hospitals & Clinics
- Diagnostic Units / Pathology Labs
- Research Institutes
- Others
Regional Insights:
The U.S. Zika virus testing market is projected to increase from USD 74.42 million in 2025 to USD 136.73 million in 2035, at a CAGR of 6.99%. Strong acceptance of advanced molecular testing technologies and multiplex testing solutions, increased readiness for Zika virus outbreaks, increased testing requirements for prenatal and neonatal diagnosis, and investments in innovative rapid, portable, and deployable testing solutions in hospital settings, labs, and government agencies all have an impact on the market.
Due to the robust health infrastructure of the United States and Canada, the North America Zika Virus Testing Market sector has a prominent market share of 40.45%, which is significant in 2025. Numerous travel-related tests, as well as developments in molecular diagnostic technologies, such as Zika virus testing as part of prenatal care, have made this possible.
With a CAGR of 8.84%, Asia-Pacific has the fastest growth rate due to a high mosquito density, rising epidemic risks, and expanding government-initiated screening initiatives. This expansion is driven by nations, such as Oceania, Southeast Asia, and India.
Recent Developments:
- In September 2025, Roche announced the launch of a next‑generation multiplex PCR kit designed for simultaneous detection of arboviruses, enhancing outbreak preparedness and maternal health screening.
- In July 2025, Abbott introduced a portable Zika rapid test kit with enhanced reagent stability for tropical climates, aimed at expanding access in Latin America and Asia-Pacific.
Exclusive Sections of the Report (The USPs):
- TESTING ADOPTION & PUBLIC HEALTH UTILIZATION METRICS – helps you understand market demand through insights on hospital and lab adoption rates, outbreak-driven testing volumes, use of rapid kits vs. PCR testing, and inclusion in prenatal and neonatal screening programs.
- DIAGNOSTIC PERFORMANCE & LABORATORY EFFICIENCY BENCHMARKS – helps you evaluate reliability through turnaround time comparisons, diagnostic accuracy, sensitivity and specificity metrics, reagent availability, and utilization of confirmatory testing protocols.
- ADVANCED DIAGNOSTIC TECHNOLOGY & INNOVATION LANDSCAPE – helps you identify growth opportunities through adoption of multiplex assays, portable PCR systems, miniaturized diagnostics, automated reporting, and innovations in reagent stability.
- OUTBREAK-DRIVEN DEMAND & REGIONAL MARKET INSIGHTS – helps you assess market dynamics through regional testing trends, outbreak response strategies, travel-related screening demand, and case studies demonstrating improved containment.
- HEALTHCARE INFRASTRUCTURE & END-USER DEMAND ANALYSIS – helps you uncover growth potential through demand across hospitals, diagnostic labs, prenatal care centers, and public health agencies, driven by increasing awareness and routine screening initiatives.
Buy an Enterprise-User PDF of Zika Virus Testing Market Outlook Report 2026-2035: https://www.snsinsider.com/checkout/9896
Zika Virus Testing Market Report Scope
| Report Attributes | Details |
| Market Size in 2025 | USD 239.91 Million |
| Market Size by 2035 | USD 480.44 Million |
| CAGR | CAGR of 7.28% From 2026 to 2033 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Related Market Reports
Infectious Disease Diagnostics Market
Dengue Testing Market
Newborn Screening Market
Molecular Diagnostics Market
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: info@snsinsider.com
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Publication takes no editorial responsibility for the same.
